STI-GC BASHH 2018

Question 1

What is 1st line treatment GC (no sensitivity)

Answer 1

1g Ceftriaxone IM STAT

(same in pregnancy/BF)

Question 2

Epidemiological treatment of GC in sexual partners is only recommended if presenting with …….days of exposure to infection

Answer 2

14 days

> 14 days await test first
Could test first if asymptomatic < 14 days

Question 3

If using non first line treatment for GC all regimes include what drug as dual therapy? (not pregnant/BF)

Answer 3

Azithromycin 2g stat

Question 4

Who should you tell if possible ceftriaxone resistant GC?

Answer 4

PHE (and ghostbusters)

Question 5

How long should you avoid sexual contact for after GC treatment?

Answer 5

7 days

Question 6

How long should PN cover is asymptomatic GC at any site?

Answer 6

3/12

Question 7

How long should PN cover if symptomatic male urethral GC

Answer 7

2/52

Question 8

Who should be offered TOC in GC?

Answer 8

Everyone (at 2 weeks should be negative whatever NAAT used)

Question 9

If pregnant or BF and can’t give ceftriaxone what are alternatives?

Answer 9

Spectinomycin 2g or Azithromycin 2g

AZT says should have sensitivity first and only if no alternate

Spectinomycin says if no alternate and caution in BF as not known if excreted

Question 10

What is oral alternative to Ceftriaxone if needle phobic?

Answer 10

400mg Cefixime stat and AZT 2g